Patient-Reported Outcomes Dashboard With Goal Setting to Support Shared Decision-Making in Inflammatory Arthritis
- NCT ID
- NCT07865390
- Registry status
- Not yet recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- Northwestern University
- Conditions
- Arthritis, Psoriatic (PsA), Arthritis, Rheumatoid (RA)
Overview
ClinicalTrials.gov lists this study as Not yet recruiting.
Official title: Personalizing Inflammatory Arthritis Rheumatology Care: Integrating PROMIS Measures and Patient Preferences to Improve Shared Decision-Making
Enrollment: 160 participants (Estimated).
What is being studied
- Other: Patient-Reported Outcomes Dashboard With Goal Setting
Who may be eligible
- Ages
- 18 Years to no maximum
- Sex
- All
- Healthy volunteers accepted
- No
ClinicalTrials.gov lists the following eligibility criteria.
Study locations
1 study location is listed.
Site recruitment status is not specified in the registry data for these locations.
Countries: United States
- Illinois, United States: 1
Sample of listed locations
- Northwestern Medicine Rheumatology — Chicago, Illinois, 60611, United States — Site recruitment status not specified in the registry data
Study details
- Start date
- November 16, 2026
- Primary completion date
- December 31, 2027
- Completion date
- February 29, 2028
- First posted
- October 8, 2026
Source and update information
- Source
- ClinicalTrials.gov
- NCT ID
- NCT07865390
- Registry last updated
- October 8, 2026
- QualifiedStudies registry data refreshed
- October 12, 2026
- QualifiedStudies record fetched
- October 12, 2026
View NCT07865390 on ClinicalTrials.gov
Trial information can change. Confirm current study details with the study team or the registry.
About joining clinical research
Find clinical trials you may match with
QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.
Find clinical trials you may match with | Arthritis studies | Clinical trial FAQ